Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study

Z. PAN (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), N. Blank (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), C. Fiehn (Baden-Baden, Germany), J. Song (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), A. Marra (Naples, Italy), C. Fischer (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)

Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Session: Risk stratification in treatment of pulmonary arterial hypertension
Session type: Oral Presentation
Number: 272
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. PAN (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), N. Blank (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), C. Fiehn (Baden-Baden, Germany), J. Song (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), A. Marra (Naples, Italy), C. Fischer (Heidelberg, Germany), E. Grünig (Heidelberg, Germany). Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study. 272

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: